Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67025-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- DDX5 antibody
- Antibody type
- Monoclonal
- Description
- DDX5 antibody (Cat. #67025-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2D3D2
- Vial size
- 20ul, 150ul
Submitted references DEAD box RNA helicase 5 is a new pro-viral host factor for Sindbis virus infection.
VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma.
Polymerase η Recruits DHX9 Helicase to Promote Replication across Guanine Quadruplex Structures.
LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis.
Messmer M, Pierson L, Pasquier C, Djordjevic N, Chicher J, Hammann P, Pfeffer S, Girardi E
Virology journal 2024 Mar 29;21(1):76
Virology journal 2024 Mar 29;21(1):76
VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma.
Yang S, Zhou P, Zhang L, Xie X, Zhang Y, Bo K, Xue J, Zhang W, Liao F, Xu P, Hu Y, Yan R, Liu D, Chang J, Zhou K
Cancer biology & therapy 2023 Dec 31;24(1):2230641
Cancer biology & therapy 2023 Dec 31;24(1):2230641
Polymerase η Recruits DHX9 Helicase to Promote Replication across Guanine Quadruplex Structures.
Tang F, Wang Y, Gao Z, Guo S, Wang Y
Journal of the American Chemical Society 2022 Aug 10;144(31):14016-14020
Journal of the American Chemical Society 2022 Aug 10;144(31):14016-14020
LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis.
Li Y, Liu X, Cui X, Tan Y, Wang Q, Wang Y, Xu C, Fang C, Kang C
Theranostics 2021;11(9):4516-4530
Theranostics 2021;11(9):4516-4530
No comments: Submit comment
No validations: Submit validation data